San Diego-based Ardea Biosciences, which is developing small-molecule therapeutics for the treatment of HIV, gout, cancer and inflammatory diseases, announced Thursday that the firm has scored an $8M growth capital loan from Oxford Finance Corporation and Silicon Valley Bank. The firm said the financing will go towards funding operations in the second half of 2009.